Paraphase – a computational tool that accurately resolves and analyzes paralogous genes – unlocks the difficult-to-analyze ...

It is caused by the absence or defect of the SMN1 gene, which leads to a deficiency of a protein essential for the survival of motor neurons, cells responsible for movement, breathing, and swallowing.

Food sensitivity tests promise to reveal your trigger foods. But due to false positives and unreliable methods, they're not advised. Here's what to consider instead.

ASCO 25: Roche places Itovebi marker in breast cancer. Roche's Itovebi has become the first PI3K inhibitor to extend survival in HR-positive, HER2-negative breast cancer with a PIK3CA mutation.

Novartis is set to launch its one-off gene therapy Zolgensma for the ultra-rare muscle-wasting disease spinal muscular atrophy (SMA) in Germany at the start of July priced at 1,945,000 euros, and ...

Find Australia cricket Test matches team series results at ESPNcricinfo. Records and stats of Australia Test matches team series results.

Biogen is currently engaging with global health authorities regarding the design of the Phase 3 studies. Biogen licensed the global development, manufacturing and commercialization rights for ...

In a Phase I study, previously treated pediatric SMA patients exhibited reductions in a marker of neurodegeneration after salanersen treatment.

Doesn’t test for other sleep problems: At-home tests only measure breathing, heart rate, and oxygen levels. They don’t detect other common sleep disorders, such as narcolepsy.

SMA Type 1 is caused by a mutation in the SMN1 gene, leading to the deterioration of motor neurons. Left untreated, it is often fatal within the first two years of life.

Skeletal muscle organoids (SKMOs), neuromuscular organoids (NMOs), and assembloids have emerged as powerful in vitro models that simulate the intricate cellular interactions between muscle and nerve, ...